Chloë Kaal

Guest Researcher

Chloë holds a bachelor’s degree in Biology, specialized in medical and molecular biology, and a master’s degree in Molecular Mechanisms of Disease from the Radboud University Nijmegen, focused on studying underlying processes of disease and translating them into treatments for patients. During her internship and employment at AST in the research group of prof. Passier, she worked on maturation of hiPSC-derived cardiomyocytes in a heart-on-chip model. Currently, Chloë works as Assistant Scientist at AST’s spin-off company River BioMedics, where she aims to translate research on heart disease models to effective treatment for patients.